Holliston

Holliston organ implant company Biostage is offering roughly $8 million in stock, three months after it was threatened to be removed from the NASDAQ stock exchange.

Holliston sensors manufacturer Nanmac Corp. was purchased in 2014 by the Patriot Worldwide, also based in Holliston. Since the acquisition, the company has been selling its products to the likes of Boeing, Raytheon, Lockheed Martin and Saint-Gobain, trying to grow its market share for temperature-sensing devices.

The region's latest Movers & Shakers.

Greater Boston Commercial Properties of Northborough announced four leasing deals totaling more than 25,000 square feet and the procurement for a direct buyer of a 38,000 square foot building, all in MetroWest.

Bioengineered organ transplant company Biostage's stock lept more than 25 percent after the company announced it received a designation that will save the company time and money as it pushes its throat transplant technology to the market.

Home sales throughout MetroWest slipped in October, following a statewide trend that marked only the second time this year that sales did not grow over the previous year's numbers, according to The Warren Group.

Holliston's Biostage organ implant company has been given 180 days to raise its stock price above $1 or risk delisting from the NASDAQ stock market.

Holliston's Biostage will need to raise more money to get to human trials of its bioengineered organ implants to treat throat cancers as its third quarter losses exceed $3 million with a little over $6 million left in cash on hand.

Holliston life sciences manufacturer Harvard Bioscience announced Friday it sold its Germany liquid handling product maker for $1.7 million.

Hopkinton commercial solar installer Solect Energy plans to open a Holliston warehouse by mid-2017.